Quality improvement in haemodialysis process using FMEA

International Journal of Quality and Reliability Management

Volumn 26, Issue 8, 2009, Pages 817-830

  Ookalkar, A D ^a   Joshi, Anil G ^b   Ookalkar, Dhananjay S ^a  

^a Ashwini Kidney Center   (India)

^b Ascent Academy   (India)

Author keywords

Failure modes and effects analysis; Health services; Quality; Training

Indexed keywords

EID: 70350374096     PISSN: 0265671X     EISSN: None     Source Type: Journal    
DOI: 10.1108/02656710910984183     Document Type: Article

References (14)

1. Arduino, M.J., Lucero, C. and Patel, P. (2008), "Infections in dialysis patients", Nephrology - News & Issues, Vol. 22 No. 2, pp. 48-57.
2. ASQC & AIAG (2001), Potential FMEA Reference Manual, 3rd ed., American Society for Quality Control and Automotive Industry Action Group, Southfield, MI.
3. CDC (1998), Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease MMWR Recommendations & reports, pp. 1-39, 47(RR19), October 16, 1998.
4. Day, S.S., Dalto, J.J., Fox, J.J., Allen, A.A. and Ilstrup, S.S. (2007), "Utilization of failure mode effects analysis in trauma patient registration", Quality Management in Health Care (Qual Manag Health Care), Vol. 16 No. 4, pp. 342-8.
5. Day, S., Dalto, J., Fox, J. and Turpin, M. (2006), "Failure modes and effects analysis as a performance improvement tool in trauma", J.trauma Nurs, Vol. 13 No. 3, pp. 111-7.
6. Jaiswal, S., P,., Chitnis, D.S., Salgia, P., Sepaha, A. and Pandit, C.S. (2002), "Prevalence of Hepatitis C viruses among chronic renal failure haemodialysis patients in Central India", Dial Transplant, Vol. 31 No. 4, pp. 234-40.
7. Mathurin, P., Mouqet, C., Poynard, T., Sylla, C., Benalia, H., Fretz, C., Thibault, V., Cadranel, J.F., Bernard, B. and Opolon, P. (1999), "Impact of hepatitis B and C virus on kidney transplantation outcome", Hepatology, Vol. 29 No. 1, pp. 257-63.
8. Mekki, K.S. (2006), "Robust design failure mode and effects analysis in designing for six sigma", International Journal of Product Development, Vol. 3 Nos 3/4, pp. 292-304.
9. Nissenson, A. and Fine, R.N. (2005), "Liver disease in dialysis patients (24)", Clinical Dialysis, 4th ed., p. 660.
10. Paparella, S.S. (2007), "FMEA: a useful tool for risk identification and injury prevention", Journal of Emergency Nursing: JEN (J Emerg Nurs), Vol. 33 No. 4, pp. 367-71.
11. Reid, D. (2005), "FMEA - something new something old", Quality Progress, Vol. 38 No. 5, pp. 92-3.
12. Shibamoto, T. (2001), "On the optimal conditions for infection control haemodialysis facilities", Journal of Japanese Society for Dialysis Therapy, Vol. 34 No. 5, pp. 329-34.
13. Trapskin, P.J., White, L. and Armitstead, J.A. (2006), "Improving the accuracy of patient identification in the medication-use process", Am J Health-Syst Pharm, Vol. 63 No. 3, pp. 218-22.
14. Whitby, M., McLaws, M.-L. and Ross, M.W. (2006), "Why healthcare workers don't wash their hands: a behavioral explanation", Infection Control and Hospital Epidemiology, Vol. 27 No. 5, pp. 484-92.